Neogenomics Inc. NEO

NAS: NEO | ISIN: US64049M2098   30/04/2025
6,395 USD (-2,81%)
(-2,81%)   30/04/2025

29 april 2025 · NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform · Persbericht

28 januari 2023 · NEOGENOMICS SHAREHOLDER NOTICE:Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In NeoGenomics To Contact Him Directly To Discuss Their Options · Persbericht

26 januari 2023 · NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit · Persbericht

24 januari 2023 · NEO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of NeoGenomics, Inc. Shareholders · Persbericht

24 januari 2023 · NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NeoGenomics, Inc. (NASDAQ: NEO) · Persbericht

23 januari 2023 · ROSEN, A TOP RANKED LAW FIRM, Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NEO · Persbericht

23 januari 2023 · CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NeoGenomics Investors of a Lead Plaintiff Deadline of February 6, 2023 · Persbericht

21 januari 2023 · NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO · Persbericht

9 januari 2023 · NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit · Persbericht

7 januari 2023 · NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO · Persbericht

24 december 2022 · NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO · Persbericht

12 december 2022 · Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate · Persbericht

10 december 2022 · NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO · Persbericht

10 januari 2022 · New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024 · Persbericht

16 maart 2021 · Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study · Persbericht

2 februari 2021 · NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition · Persbericht

Mijn selecties